Reported 5 months ago
The article discusses two stocks that have the potential to increase tenfold by 2035. The first stock is Viking Therapeutics, a biotech company working on anti-obesity medicines with promising clinical trial results, potentially offering a pill alternative to injectable treatments. The second stock is Recursion Pharmaceuticals, using artificial intelligence to improve the drug development process, potentially revolutionizing the industry. While both stocks have high growth potential, there are risks involved, and investors are advised to carefully monitor and consider these factors before investing.
Source: YAHOO